pharmaphorum

MAY 26, 2022

Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a wide-scale war in Ukraine. Russia’s full-scale invasion of Ukraine has already affected the global pharmaceutical industry a lot. This is especially important now, when Ukraine is engulfed by war. .

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

Pharmaceutical Technology

JULY 21, 2022

The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world. According to the World Health Organization (WHO), two billion people lack access to essential or basic drugs. Healthy and safe citizens are critical to functioning economies. Access to medication.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 19, 2022

Taking a brief look back to pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and excellence”. Nonetheless, the more recent and ongoing crisis in Ukraine saw YCE being the first responder in that country.

Documentation 83

Documentation Hospitals Communication Vaccines 83

Viseven

OCTOBER 31, 2023

Today, marking the culmination of Breast Cancer Month, I share a chapter from my life – the story of Nataliya Andreychuk, a cancer survivor and the CEO of Viseven, a healthcare digital marketing agency rooted in Ukraine and dedicated to partnering with the Pharma and Life Sciences sectors. What fortified me during those trying times?

Chemotherapy 52

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

AUGUST 12, 2022

OxfordVR uses VR headsets to simulate real-world everyday scenarios for patients that are often associated with increased anxiety and stress. The VR headsets offer a virtual coach that guides the patient through the scenarios using CBT methods.

FDA 141

FDA 141

pharmaphorum

JANUARY 27, 2023

Almost one year ago, the new German coalition government reacted to the Russian invasion of Ukraine with a significant reversal of established policies in several fields, declaring that Europe and the world were experiencing a “Zeitenwende” – a time of major historical change.

Packaging 94

Packaging Vaccines 94

Pharmaceutical Technology

DECEMBER 27, 2022

In a recap of this eventful year, we take a moment to look at some of our biggest stories that relied on data and experts to inform our audience about the latest developments in the world of pharma, medical devices, and clinical trial operations. Tracking the news.

Vaccines 122

Vaccines 122

pharmaphorum

JANUARY 5, 2023

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with Greg Rossi, senior vice president, head of oncology Europe and Canada at AstraZeneca.

52

52

pharmaphorum

AUGUST 12, 2022

The war in Ukraine, which has left it dependent on emergency aid, exposed the consequential link between a country’s pharmaceutical supplies and its geopolitics. The conflict in Ukraine once again underscores how quickly the status quo can break down and lead to vital drug shortages that put public health in dire straits.

Packaging 58

Packaging 58

pharmaphorum

NOVEMBER 9, 2022

It goes without saying that The Economist’s 8th Annual World Cancer Series congress was well-attended in Brussels this week, the unofficial capital of the European Union. The post Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i) appeared first on. In short, health systems have been shaken.

Insurance 93

Insurance 93

European Pharmaceutical Review

DECEMBER 23, 2022

This responsibility has increased significantly in recent years, due to the COVID-19 pandemic ; the war in Ukraine; rising energy costs and inflation and the increase in geopolitical tensions globally – all of which are creating unprecedented upheaval and disruptions to global supply chains.

Vaccines 85

Vaccines Communication 85

Pharmaceutical Technology

NOVEMBER 4, 2022

The Covid-19 pandemic , Brexit , the Russian war against Ukraine , and a subsequent global inflation crisis have caused a difficult economic climate in the UK for any PM to take on. The letter reported that the UK fell from fifth place in 2017 to seventh in 2020 for the number of Phase III clinical trials initiated across the world.

Documentation 93

Documentation Pharmaceutical Companies Pharmaceutical Companies 93

Pharmaceutical Technology

OCTOBER 13, 2022

War in Ukraine created bitter headwinds in energy markets, and businesses are being buffeted. It’s about trying to get the finance world to take a step forward,” says Darren Rivas, CEO of Capitas. “We But there is a long way to go. Fuel costs alone have trebled for some firms. Rhetoric versus action.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

OCTOBER 5, 2022

As health services around the world seek to recover from Covid-19, many are turning to healthtech to expand treatment options and increase efficiencies. However, due to the ongoing war in Ukraine, it remains to be seen what impact this will have on Russia’s 2022 figures. In 2021, the UK accounted for 14.9%

Compounding 52

Compounding 52

The Checkup by Singlecare

MAY 4, 2023

Sometimes referred to as “golden blood,” fewer than 50 people in the world have this type of blood. Certain rare blood types are unique to specific racial and ethnic groups; for example, U-negative and Duffy-negative blood types are only found among African-Americans.

Immunization 98

Immunization Hospitals 98

Pharmaceutical Technology

JUNE 30, 2022

The World Health Organization (WHO) classifies 20 conditions as neglected tropical diseases, including Chagas disease, human African trypanosomiasis (also known as sleeping sickness), and leishmaniasis. But tropical diseases are unique, and some need investment in structural programs rather than just the creation of new therapeutics.

Vaccines 64

Vaccines FDA Hospitals 64

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Several global pharma companies have already withdrawn their support following Russia’s invasion of Ukraine, which began on 24 February.

Vaccines 122

Vaccines Packaging FDA 122

ISPE

MAY 10, 2023

Cybersecurity threats, the global pandemic, and the Russia-Ukraine conflict have shown us that supply chain disruptions are bound to happen and that we need to increase efficiency, flexibility, and resiliency. And the whole system is going to evolve such that there will be a consolidation of providers and payers and nontraditional players.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 30, 2023

Across the world, there are reports of shortages of common antibiotics. In many countries across the world, there are shortages of common antibiotics. Ben Hargreaves examines why these shortages are happening and what is being done in the background to return supply to normal. of global antibiotic exports by value.

Generic Medicine 91

Generic Medicine Packaging FDA Labelling 91

European Pharmaceutical Review

FEBRUARY 2, 2023

Inflation increases supply vulnerabilities across Europe Having barely emerged from the pandemic, manufacturers have again seen global supply chains put under pressure from the war in Ukraine, which has resulted in hugely inflated energy prices putting Europe’s medicines supplies at further risk. We need to reverse that. ”

Generic Medicine 102

Generic Medicine Packaging Documentation Pharmaceutical Companies 102

pharmaphorum

MAY 11, 2022

As a Global Marketing Technology Services Provider for Life Sciences and Pharma industries with over a decade of experience, Viseven continues to deliver exceptional services for its clients around the world. The world connected by digital capacities leaves no space for uncertainty.

Communication 52

Communication 52

ISPE

FEBRUARY 13, 2023

After retiring from TGA Bob remained an active consultant, guiding many GMP regulatory authorities around the world reach the PIC/S level of regulatory control. While at TGA Bob also served as Deputy Chairman of PIC/S during 1998-1999, followed by a tenure as Chairman of PIC/S from 2000-2001.

Documentation 98

Documentation FDA 98

ISPE

OCTOBER 1, 2023

Reveal the hidden challenges, opportunities, and trends impacting validation and quality professionals like you, with the world's first annual validation industry survey and report—the State of Validation. In this guide, you will learn: How your salary compares to other validation and quality professionals. Outlying Islands U.S.

Communication 52

Communication 52

ISPE

NOVEMBER 4, 2022

It shares steps involved in developing a cleaning validation process and a real-world example of how a manufacturer optimized their cleaning validation process to be more efficient while maintaining their compliance and risk. Download White Paper. To download this white paper, complete the form below. Outlying Islands U.S.

Communication 52

Communication 52

ISPE

OCTOBER 28, 2022

These are the basis of the company’s work to expand offerings and make them available broadly around the world through its BioNTainers concept, a modular and scalable vaccine production approach for which models are being developed. Partnering with suppliers that can keep the necessary items coming is critical. Efficiency for responsiveness.

Vaccines 52

Vaccines FDA Immunization 52

ISPE

MARCH 6, 2023

Transforming Our World: The 2030 Agenda for Sustainable Development.” “Green Manufacturing for the Pharmaceutical Industry.” 7 December 2017. link] 2 United Nations. Department of Economic and Social Affairs: Sustainable Development. October 2015. link] 3 AstraZeneca. Sustainability Report 2021.” link] 4 US Green Building Council.

Communication 52

Communication Patient Care 52

ISPE

JANUARY 9, 2023

The 2nd Edition highlights the use of critical thinking by knowledgeable and experienced subject matter experts (SMEs) to define appropriate approaches. Outlying Islands U.S.

Documentation 52

Documentation FDA Communication 52

ISPE

SEPTEMBER 11, 2023

link] 4 World Health Organization. Revised Annex 1 (Manufacture of Sterile Medicinal Products) to Guide for Good Manufacturing Practice for Medicinal Products” Published 9 September 2022. Annex 2: WHO Good Manufacturing Practices for Pharmaceutical Products.” Published 31 October 2022. link] 5 Naughton, P. History of Cleanrooms.”

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

DECEMBER 14, 2022

Annex 1 (2022) – The Brave New World of Regulatory Compliance. Annex 1 (2022) – The Brave New World of Regulatory Compliance. Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis & Futuna Western Sahara Yemen Zambia Zimbabwe Åland Islands.

Communication 98

Communication FDA 98

pharmaphorum

MAY 6, 2022

The separation makes EuroAPI the world’s single largest producer of small-molecule active pharmaceutical ingredients (APIs) – and the second-largest API producer overall after Israel’s Teva – with a market valuation of more than $1.2

63

63

ISPE

MARCH 6, 2023

5 a b World Resources Institute and World Business Council for Sustainable Development. Two Real-World Experiences in Global Sustainability.” 12 “Emissions Factors 2022: Annual GHG Emission Factors for World Countries from Electricity and Heat Generation.” World Business Council for Sustainable Development website.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. link] 8 World Health Organization. Published November 2017.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MAY 9, 2023

We teach real-world applications when it comes to making medicine, from the innovation to create novel cures to large-scale manufacturing processes,” said Leslie Isenhour, Dean, Biotechnologies Division, Wake Technical Community College. 5 US News & World Report: Real Estate. And they were right.” Accessed 18 January 2023.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

Viseven

JUNE 17, 2022

By this moment, four months of full-scale conquest war of Russia against Ukraine feel like a single day, and this day feels like years have gone by. Ukraine is close to our company’s heart. Ukraine’s battle runs in all fields: military, economic, informational, political, and social. The Battle On All Fronts.

Communication 52

Communication 52

ISPE

MARCH 7, 2023

Transforming Our World: The 2030 Agenda for Sustainable Development.” link] 14 World Resources Institute and World Business Council for Sustainable Development. Research and development, manufacturing, commercial (sales and marketing) activities, and their extended supply chains including logistics are all within this scope.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 15, 2023

3 The pharmaceutical industry, while providing life-saving and empowering services to the world, recognizes the UN’s recommendation that every sector contribute to comprehensive environmental sustainability, included in COP27. Transforming Our World: The 2030 Agenda for Sustainable Development.” link] 4 World Economic Forum. “3

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

Pharmaceutical Technology

MARCH 17, 2023

On 16 March, Watt spoke at GlobalData webinar titled “Pharma [POLI]: Market Access Risk Outlook”, providing a current outlook on the pharmaceutical pricing and reimbursement environments around the world, including key reforms, risks and opportunities. This may be because access to oncology drugs varies widely across the world, she added.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102